The European Union and Japan have granted patents to the universal flu vaccine Multimeric-001 (M-001) developed by Israel’s BiondVax.  The ex-Weizmann Institute technology already has patents in the United States, Hong Kong, Australia, China, Russia and Mexico.

http://www.timesofisrael.com/israels-universal-flu-vaccine-heads-for-universal-acceptance/